… Preliminary studies have reported the efficacy of biological-targeting treatments such as
TNF… , but long-term outcome and comparison to disease-modifying antirheumatic drugs and …

… efficacy of TNFi in the treatment of TAK and is the first report, to our knowledge, investigating
the efficacy and safety of secukinumab for patients with TAK refractory to initial treatment. …

… However, data is still limited for the comparative efficacy, safety, and drug survival with
biologic agents in patients with TAK. In this multicenter retrospective study from experienced …

… treatment of Takayasu arteritis and shed light on a novel treatment target in Takayasu arteritis.
… time points and baseline; #comparison between the TOF group and MTX group at different …

… in the treatment of these two vasculitides is expanding, especially in relapsing or refractory
diseases. In this review, the efficacy, … Therefore, this study does not report a direct comparison …

… The aim of this study is to summarise comparative studies focusing on any type of clinical …
regarding safety and effectiveness of interventions in the clinical management of TA. However, …

… The pharmacotherapy of Takayasu arteritis (TAK) with disease-modifying anti-rheumatic …
and observational studies reporting the effectiveness of DMARDs in TAK identified four …

… DMARD in TA failed to show efficacy of abatacept in reducing … cyclophosphamide have shown
clinical efficacy in case series… or endovascular, is the treatment of choice to relieve critical, …

… Takayasu arteritis and Takayasu’s arteritis were searched in combination with the following
key words: treatment, management… is no randomized study comparing the efficacy of different …

… appeared to be an efficacious, safe, and GC-sparing agent for TAK treatment. In the present
study, we found that MTX showed relatively good effectiveness for TAK treatment with a CR …